BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo ZB, Lai GE, Jiang T, Cao CL, Peng T, Liu FE. A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer. Technol Cancer Res Treat 2020;19:1533033820983293. [PMID: 33371806 DOI: 10.1177/1533033820983293] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Muluhngwi P, Klinge CM. Identification and Roles of miR-29b-1-3p and miR29a-3p-Regulated and Non-Regulated lncRNAs in Endocrine-Sensitive and Resistant Breast Cancer Cells. Cancers (Basel) 2021;13:3530. [PMID: 34298743 DOI: 10.3390/cancers13143530] [Reference Citation Analysis]
2 Qin S, Ning M, Liu Q, Ding X, Wang Y, Liu Q. Knockdown of long non-coding RNA CDKN2B-AS1 suppresses the progression of breast cancer by miR-122-5p/STK39 axis. Bioengineered 2021;12:5125-37. [PMID: 34374638 DOI: 10.1080/21655979.2021.1962685] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Xu F, Huang X, Li Y, Chen Y, Lin L. m6A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD. Mol Ther Nucleic Acids 2021;24:780-91. [PMID: 33996259 DOI: 10.1016/j.omtn.2021.04.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]